ong term follow-up after a Salter pelvic osteotomy.

Completed

• Conditions: 10005944; Congenital hip dysplasia; developmental hip dysplasia; 10028396

• Registration Number: NL-OMON41976
• Lead Sponsor: niversitair Medisch Centrum Sint Radboud

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 77

Inclusion Criteria

Healthy patients after a Salter pelvic osteotomy performed at our hospital who are now 16 or older.

Exclusion Criteria

- Patients with comorbidities influencing the outcome of hip dysplasia, such as Down's syndrome or cerebral palsy.
- Patients under 16 years old.

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>- VAS scores<br /><br>- Range of motion<br /><br>- Harris hip score<br /><br>- Oxford hip questionnaire<br /><br>- Merle d'Aubigne score<br /><br>- Radiological presence of osteoarthritis<br /><br>- Total hip arthroplasty</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>- Postoperative complications</p><br>